Previous studies have revealed that BRCA1 mutation contributes to breast cancer development by creating a pro-tumorigenic niche and affects the transformation of CAFs to metastasis associated fibroblasts (MAFs). The gene discussed is BRCA1; the disease is breast carcinoma.